3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Tranexamic Acid
2
carbetocin
1
Sutures
1
Surgicel
1
Solutions
1
Sodium Chloride
1
Saline Solution
1
Neuromuscular Blockade
1
N(4)-oleylcytosine arabinoside
1
Methylergonovine
1
Injections, Intravenous
1
FloSeal Matrix
1
Ergonovine
1
Endoscopic Mucosal Resection
1
Bevacizumab
1
Aspirin
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemorrhage
×
N(4)-oleylcytosine arabinoside
×
1 year
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled